Effect of Rifampin on the Pharmacokinetics of Intravenous (IV) Vinflunine in Subjects With Advanced Cancer
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2015
At a glance
- Drugs Vinflunine (Primary) ; Rifampicin
- Indications Bacterial infections; Cancer
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 30 Apr 2008 The expected completion date for this trial is now 1 Nov 2008.
- 30 Oct 2007 New trial record.